Results 201 to 204 of about 7,789 (204)

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial

Lancet, The, 2018
Gerd R Burmester, Joel M Kremer, Filip E Van Den Bosch   +2 more
exaly  

Pharmacokinetics of Upadacitinib With the Clinical Regimens of the Extended‐Release Formulation Utilized in Rheumatoid Arthritis Phase 3 Trials

Clinical Pharmacology in Drug Development, 2019
Ahmed A Othman, Fcp
exaly  

Upadacitinib for the treatment of rheumatoid arthritis

Expert Review of Clinical Immunology, 2019
exaly  

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

New England Journal of Medicine
exaly